Beam Therapeutics's total assets for Q3 2025 were $1.31B, a decrease of -5.76% from the previous quarter. BEAM total liabilities were $345.08M for the fiscal quarter, a 0.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.